Related posts:

1. Preclinical Studies for Gene Therapy of Duchenne Muscular Dystrophy.
2. Molecular Therapeutic Strategies Targeting Duchenne Muscular Dystrophy.
3. Aging with muscular dystrophy: pathophysiology and clinical management.
4. Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans.
5. Functional and molecular effects of arginine butyrate and prednisone on muscle and heart in the mdx mouse model of Duchenne Muscular Dystrophy.

Tags: Muscular Dystrophy

This entry was posted on Monday, January 31st, 2011 at 6:52 am and is filed under Muscular Dystrophy. You can follow any responses to this entry through the RSS 2.0 feed. You can skip to the end and leave a response. Pinging is currently not allowed.